What has passed is prolog: new cellular and physiological roles of G6PD

Free Radical Research

Volumn 50, Issue 10, 2016, Pages 1047-1064

  Yang, Hung Chi ^a,b   Wu, Yi Hsuan ^a   Liu, Hui Ya ^a   Stern, Arnold ^c   Chiu, Daniel Tsun Yee ^a,b,d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

G6PD; NADPH; NOS; NOX; oxidative stress; reactive oxygen and nitrogen species

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR NRF2;

CELL METABOLISM; EMBRYO DEVELOPMENT; ENERGY CONSUMPTION; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GLUTATHIONE METABOLISM; HISTONE ACETYLATION; HUMAN; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHAGOCYTE; PROTEIN ACETYLATION; PROTEIN PROCESSING; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; XENOBIOTIC METABOLISM; ANIMAL; MOUSE;

ANIMALS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MICE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84994259884     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715762.2016.1223296     Document Type: Review

References (252)

1. L.Longo, O.C.Vanegas, M.Patel, V.Rosti, H.Li, J.Waka,. Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J 2002;21:4229–4239.
2. H.C.Yang, T.L.Chen, Y.H.Wu, K.P.Cheng, Y.H.Lin, M.L.Cheng,. Glucose 6-phosphate dehydrogenase deficiency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans. Cell Death Dis 2013;4:e616.
3. E.Beutler G6PD deficiency. Blood 1994;84:3613–3636.
4. P.P.Pandolfi, F.Sonati, R.Rivi, P.Mason, F.Grosveld, L.Luzzatto Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD):G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J 1995;14:5209–5215.
5. L.Luzzatto, E.Seneca G6PD deficiency:a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol 2014;164:469–480.
6. G.H.Wan, S.C.Tsai, D.T.Chiu Decreased blood activity of glucose-6-phosphate dehydrogenase associates with increased risk for diabetes mellitus. Endocrine 2002;19:191–195.
7. R.S.Gaskin, D.Estwick, R.Peddi G6PD deficiency:its role in the high prevalence of hypertension and diabetes mellitus. Ethn Dis 2001;11:749–754.
8. A.Minucci, K.Moradkhani, M.J.Hwang, C.Zuppi, B.Giardina, E.Capoluongo. Glucose-6-phosphate dehydrogenase-beyond the realm of red cell biology. Blood Cells Mol Dis 2012;48:154–165.
9. E.Beutler, T.J.Vulliamy. Glucose-6-phosphate dehydrogenase-from oxidative stress to cellular functions and degenerative diseases. Blood Cells Mol Dis 2002;28:93–103.
10. H.Y.Ho, M.L.Cheng, D.T.Chiu. G6PD-an old bottle with new wine. Free Radic Res 2014;48:1028–1048.
11. H.Y.Ho, M.L.Cheng, D.T.Chiu Glucose-6-phosphate dehydrogenase–from oxidative stress to cellular functions and degenerative diseases. Redox Rep 2007;12:109–118.
12. H.Y.Ho, M.L.Cheng, D.T.Chiu G6PD–an old bottle with new wine. Chang Gung Med J 2005;28:606–612.
13. G.Sirokmany, A.Donko, M.Geiszt Nox/Duox family of NADPH oxidases:lessons from knockout mouse models. Trends Pharmacol Sci 2016;37:318–327.
14. S.P.Gray, K.A.Jandeleit-Dahm The role of NADPH oxidase in vascular disease – hypertension, atherosclerosis and stroke. Curr Pharm Des 2015;21:5933–5944.
15. Z.Nayernia, V.Jaquet, K.H.Krause New insights on NOX enzymes in the central nervous system. Antioxid Redox Signal 2014;20:2815–2837.
16. D.P.Carvalho, C.Dupuy Role of the NADPH oxidases DUOX and NOX4 in thyroid oxidative stress. Eur Thyroid J 2013;2:160–167.
17. B.Musset, R.A.Clark, T.E.DeCoursey, G.L.Petheo, M.Geiszt, Y.Chen,. NOX5 in human spermatozoa:expression, function, and regulation. J Biol Chem 2012;287:9376–9388.
18. K.Bedard, V.Jaquet, K.H.Krause NOX5:from basic biology to signaling and disease. Free Radic Biol Med 2012;52:725–734.
19. H.C.Yang, M.L.Cheng, H.Y.Ho, D.Tsun-Yee Chiu The microbicidal and cytoregulatory roles of NADPH oxidases. Microbes Infect 2011;13:109–120.
20. S.Guo, X.Chen The human Nox4:gene, structure, physiological function and pathological significance. J Drug Target 2015;23:888–896.
21. B.A.Diebold, S.M.Smith, Y.Li, J.D.Lambeth NOX2 as a target for drug development:indications, possible complications, and progress. Antioxid Redox Signal 2015;23:375–405.
22. E.P.Reeves, H.Lu, H.L.Jacobs, C.G.Messina, S.Bolsover, G.Gabella,. Killing activity of neutrophils is mediated through activation of proteases by K + flux. Nature 2002;416:291–297.
23. S.O'Neill, J.Brault, M.J.Stasia, U.G.Knaus Genetic disorders coupled to ROS deficiency. Redox Biol 2015;6:135–156.
24. V.Brinkmann, U.Reichard, C.Goosmann, B.Fauler, Y.Uhlemann, D.S.Weiss,. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532–1535.
25. E.P.Azevedo, N.C.Rochael, A.B.Guimaraes-Costa, T.S.de Souza-Vieira, J.Ganilho, E.M.Saraiva,. A metabolic shift toward pentose phosphate pathway is necessary for amyloid fibril- and phorbol 12-myristate 13-acetate-induced neutrophil extracellular trap (NET) formation. J Biol Chem 2015;290:22174–22183.
26. M.L.Cheng, H.Y.Ho, H.Y.Lin, Y.C.Lai, D.T.Chiu Effective NET formation in neutrophils from individuals with G6PD Taiwan-Hakka is associated with enhanced NADP(+) biosynthesis. Free Radic Res 2013;47:699–709.
27. C.Zhang, P.L.Li Membrane raft redox signalosomes in endothelial cells. Free Radic Res 2010;44:831–842.
28. K.Chen, S.E.Craige, J.F.Keaney, Jr. Downstream targets and intracellular compartmentalization in Nox signaling. Antioxid Redox Signal 2009;11:2467–2480.
29. K.L.Siu, L.Gao, H.Cai Differential roles of protein complexes NOX1-NOXO1 and NOX2-p47phox in mediating endothelial redox responses to oscillatory and unidirectional laminar shear stress. J Biol Chem 2016;291:8653–8662.
30. J.H.Joo, H.Oh, M.Kim, E.J.An, R.K.Kim, S.Y.Lee,. NADPH oxidase 1 activity and ROS generation are regulated by Grb2/Cbl-mediated proteasomal degradation of NoxO1 in colon cancer cells. Cancer Res 2016;76:855–865.
31. N.Coant, S.Ben Mkaddem, E.Pedruzzi, C.Guichard, X.Treton, R.Ducroc,. NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol Cell Biol 2010;30:2636–2650.
32. Y.S.Kim, M.J.Morgan, S.Choksi, Z.G.Liu TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 2007;26:675–687.
33. M.Hultqvist, P.Olofsson, F.K.Wallner, R.Holmdahl Pharmacological potential of NOX2 agonists in inflammatory conditions. Antioxid Redox Signal 2015;23:446–459.
34. S.Sorce, K.H.Krause, V.Jaquet Targeting NOX enzymes in the central nervous system:therapeutic opportunities. Cell Mol Life Sci 2012;69:2387–2407.
35. F.D.Oakley, R.L.Smith, J.F.Engelhardt Lipid rafts and caveolin-1 coordinate interleukin-1beta (IL-1beta)-dependent activation of NFkappaB by controlling endocytosis of Nox2 and IL-1beta receptor 1 from the plasma membrane. J Biol Chem 2009;284:33255–33264.
36. H.Menden, S.Welak, S.Cossette, R.Ramchandran, V.Sampath Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells. J Biol Chem 2015;290:5449–5461.
37. F.Rousset, S.Carnesecchi, P.Senn, K.H.Krause Nox3-targeted therapies for inner ear pathologies. Curr Pharm Des 2015;21:5977–5987.
38. J.Lavinsky, A.L.Crow, C.Pan, J.Wang, K.A.Aaron, M.K.Ho,. Genome-wide association study identifies nox3 as a critical gene for susceptibility to noise-induced hearing loss. PLoS Genet 2015;11:e1005094.
39. H.Morimoto, M.Kanatsu-Shinohara, T.Shinohara. Nox4 and redox signaling mediate TGF-β-induced endothelial cell apoptosis and phenotypic switch. Biol Reprod 2015;92:147.
40. J.E.Lee, K.E.Cho, K.E.Lee, J.Kim, Y.S.Bae Nox4-mediated cell signaling regulates differentiation and survival of neural crest stem cells. Mol Cells 2014;37:907–911.
41. F.Yan, Y.Wang, X.Wu, H.M.Peshavariya, G.J.Dusting, M.Zhang, F.Jiang Nox4 and redox signaling mediate TGF-beta-induced endothelial cell apoptosis and phenotypic switch. Cell Death Dis 2014;5:e1010.
42. J.Li, T.Lan, C.Zhang, C.Zeng, J.Hou, Z.Yang,. Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells. Oncotarget 2015;6:1031–1048.
43. J.L.Gregg, R.M.TurnerII, G.Chang, D.Joshi, Y.Zhan, L.Chen, J.K.Maranchie NADPH oxidase NOX4 supports renal tumorigenesis by promoting the expression and nuclear accumulation of HIF2alpha. Cancer Res 2014;74:3501–3511.
44. B.A.Di Bartolo, S.P.Cartland, L.Prado-Lourenco, T.S.Griffith, C.Gentile, J.Ravindran,. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes angiogenesis and ischemia-induced neovascularization via NADPH oxidase 4 (NOX4) and nitric oxide-dependent mechanisms. J Am Heart Assoc 2015;4:e002527. doi:10.1161/JAHA.115.002527.
45. C.X.Santos, A.D.Hafstad, M.Beretta, M.Zhang, C.Molenaar, J.Kopec,. Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2alpha-mediated stress signaling. EMBO J 2016;35:319–334.
46. C.Hirschhauser, J.Bornbaum, A.Reis, S.Bohme, N.Kaludercic, R.Menabo,. NOX4 in mitochondria:yeast two-hybrid-based interaction with complex I without relevance for basal reactive oxygen species? Antioxid Redox Signal 2015;23:1106–1112.
47. A.E.Vendrov, K.C.Vendrov, A.Smith, J.Yuan, A.Sumida, J.Robidoux,. NOX4 NADPH oxidase-dependent mitochondrial oxidative stress in aging-associated cardiovascular disease. Antioxid Redox Signal 2015;23:1389–1409.
48. P.A.Kramer, V.M.Darley-Usmar The emerging theme of redox bioenergetics in health and disease. Biomed J 2015;38:294–300.
49. A.Oliveira Gde, J.Lieberman, C.Barillas-Mury Epithelial nitration by a peroxidase/NOX5 system mediates mosquito antiplasmodial immunity. Science 2012;335:856–859.
50. M.Strengert, R.Jennings, S.Davanture, P.Hayes, G.Gabriel, U.G.Knaus Mucosal reactive oxygen species are required for antiviral response:role of Duox in influenza a virus infection. Antioxid Redox Signal 2014;20:2695–2709.
51. N.Grandvaux, M.Mariani, K.Fink Lung epithelial NOX/DUOX and respiratory virus infections. Clin Sci (Lond) 2015;128:337–347.
52. E.J.Du, T.J.Ahn, I.Kwon, J.H.Lee, J.H.Park, S.H.Park,. TrpA1 regulates defecation of food-borne pathogens under the control of the Duox pathway. PLoS Genet 2016;12:e1005773.
53. W.A.Edens, L.Sharling, G.Cheng, R.Shapira, J.M.Kinkade, T.Lee,. Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol 2001;154:879–891.
54. C.G.Zou, Q.Tu, J.Niu, X.L.Ji, K.Q.Zhang The DAF-16/FOXO transcription factor functions as a regulator of epidermal innate immunity. PLoS Pathog 2013;9:e1003660.
55. V.Chavez, A.Mohri-Shiomi, D.A.Garsin Ce-Duox1/BLI-3 generates reactive oxygen species as a protective innate immune mechanism in Caenorhabditis elegans. Infect Immun 2009;77:4983–4989.
56. R.van der Hoeven, M.R.Cruz, V.Chavez, D.A.Garsin Localization of the dual oxidase BLI-3 and characterization of its NADPH oxidase domain during infection of caenorhabditis elegans. PLoS One 2015;10:e0124091.
57. F.A.Dias, A.C.Gandara, F.G.Queiroz-Barros, R.L.Oliveira, M.H.Sorgine, G.R.Braz, P.L.Oliveira Ovarian dual oxidase (Duox) activity is essential for insect eggshell hardening and waterproofing. Meth Enzymol 2013;288:35058–35067.
58. A.van der Vliet, Y.M.Janssen-Heininger Hydrogen peroxide as a damage signal in tissue injury and inflammation:murderer, mediator, or messenger? J Cell Biochem 2014;115:427–435.
59. 2:a chemoattractant? Methods Enzymol 2013;528:237–255.
60. P.Niethammer, C.Grabher, A.T.Look, T.J.Mitchison A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009;459:996–999.
61. N.Suzuki, R.Mittler Reactive oxygen species-dependent wound responses in animals and plants. Free Radic Biol Med 2012;53:2269–2276.
62. Y.C.Hou, A.Janczuk, P.G.Wang Current trends in the development of nitric oxide donors. Curr Pharm Des 1999;5:417–441.
63. C.Bogdan Nitric oxide synthase in innate and adaptive immunity:an update. Trends Immunol 2015;36:161–178.
64. J.T.Mattila, A.C.Thomas Nitric oxide synthase:non-canonical expression patterns. Front Immunol 2014;5:478.
65. R.Olekhnovitch, P.Bousso Induction, propagation, and activity of host nitric oxide:lessons from leishmania infection. Trends Parasitol 2015;31:653–664.
66. R.J.Gryglewski, R.M.Palmer, S.Moncada Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454–456.
67. J.O.Lundberg, M.T.Gladwin, E.Weitzberg Strategies to increase nitric oxide signalling in cardiovascular disease. Nat Rev Drug Discov 2015;14:623–641.
68. J.N.Simon, D.Duglan, B.Casadei, R.Carnicer Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease. J Mol Cell Cardiol 2014;73:80–91.
69. W.Wang, Y.Lee, C.H.Lee Effects of nitric oxide on stem cell therapy. Biotechnol Adv 2015;33:1685–1696.
70. H.P.Monteiro, P.E.Costa, A.K.Reis, A.Stern Nitric oxide:protein tyrosine phosphorylation and protein S-nitrosylation in cancer. Biomed J 2015;38:380–388.
71. 2 biology. Free Radic Biol Med 2015;87:204–225.
72. D.A.Wink, J.B.Mitchell Chemical biology of nitric oxide:insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998;25:434–456.
73. K.M.Fosen, S.R.Thom Hyperbaric oxygen, vasculogenic stem cells, and wound healing. Antioxid Redox Signal 2014;21:1634–1647.
74. J.A.Bauer, W.Rao, D.J.Smith Evaluation of linear polyethyleneimine/nitric oxide adduct on wound repair:therapy versus toxicity. Wound Repair Regen 1998;6:569–577.
75. T.Kiviluoto, S.Watanabe, M.Hirose, N.Sato, H.Mustonen, P.Puolakkainen,. Nitric oxide donors retard wound healing in cultured rabbit gastric epithelial cell monolayers. Am J Physiol Gastrointest Liver Physiol 2001;281:G1151–G1157.
76. C.H.Switzer, S.A.Glynn, L.A.Ridnour, R.Y.Cheng, M.P.Vitek, S.Ambs, D.A.Wink Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. J Physiol (Lond.) 2011;32:644–651.
77. D.Vasudevan, J.R.Hickok, R.C.Bovee, V.Pham, L.L.Mantell, N.Bahroos,. Nitric oxide regulates gene expression in cancers by controlling histone posttranslational modifications. Cancer Res 2015;75:5299–5308.
78. Y.H.Zhang, C.Z.Jin, J.H.Jang, Y.Wang Molecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiology. J Physiol 2014;592:3189–3200.
79. P.J.Shami, J.O.Moore, J.P.Gockerman, J.W.Hathorn, M.A.Misukonis, J.B.Weinberg Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells. Leuk Res 1995;19:527–533.
80. M.Kaibori, K.Sakitani, M.Oda, Y.Kamiyama, Y.Masu, M.Nishizawa,. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. J Hepatol 1999;30:1138–1145.
81. Y.Zhao, P.M.Vanhoutte, S.W.Leung Vascular nitric oxide:Beyond eNOS. J Pharmacol Sci 2015;129:83–94.
82. R.F.Furchgott, P.M.Vanhoutte Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007–2018.
83. E.R.Derbyshire, M.A.Marletta Structure and regulation of soluble guanylate cyclase. Annu Rev Biochem 2012;81:533–559.
84. C.K.Chan, J.Mak, Y.Gao, R.Y.Man, P.M.Vanhoutte Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries. Am J Physiol Heart Circ Physiol 2011;301:H2313–H2321.
85. Z.Chen, X.Zhang, L.Ying, D.Dou, Y.Li, Y.Bai,. cIMP synthesized by sGC as a mediator of hypoxic contraction of coronary arteries. Am J Physiol Heart Circ Physiol 2014;307:H328–H336.
86. Y.Gao, Z.Chen, S.W.Leung, P.M.Vanhoutte Hypoxic vasospasm mediated by cIMP:when soluble guanylyl cyclase turns bad. J Cardiovasc Pharmacol 2015;65:545–548.
87. T.Ikuta, H.Sellak, N.Odo, A.D.Adekile, K.M.Gaensler Nitric oxide-cGMP signaling stimulates erythropoiesis through multiple lineage-specific transcription factors:clinical implications and a novel target for erythropoiesis. PLoS One 2016;11:e0144561.
88. O.D.Maddocks, C.F.Labuschagne, K.H.Vousden Localization of NADPH production:a wheel within a wheel. Mol Cell 2014;55:158–160.
89. C.A.Lewis, S.J.Parker, B.P.Fiske, D.McCloskey, D.Y.Gui, C.R.Green,. Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol Cell 2014;55:253–263.
90. C.F.Labuschagne, N.J.van den Broek, G.M.Mackay, K.H.Vousden, O.D.Maddocks Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep 2014;7:1248–1258.
91. J.Fan, J.Ye, J.J.Kamphorst, T.Shlomi, C.B.Thompson, J.D.Rabinowitz Quantitative flux analysis reveals folate-dependent NADPH production. Nature 2014;510:298–302.
92. J.L.Vives Corrons, E.Feliu, M.A.Pujades, F.Cardellach, C.Rozman, A.Carreras,. Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections:description of a new molecular variant (G6PD Barcelona). Blood 1982;59:428–434.
93. K.J.Tsai, I.J.Hung, C.K.Chow, A.Stern, S.S.Chao, D.T.Chiu Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose-6-phosphate-dehydrogenase-deficient granulocytes. FEBS Lett 1998;436:411–414.
94. B.Wolach, M.Ashkenazi, R.Grossmann, R.Gavrieli, Z.Friedman, N.Bashan, D.Roos Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel. Pediatr Res 2004;55:807–813.
95. A.Castegna, P.Scarcia, G.Agrimi, L.Palmieri, H.Rottensteiner, I.Spera,. Identification and functional characterization of a novel mitochondrial carrier for citrate and oxoglutarate in Saccharomyces cerevisiae. J Biol Chem 2010;285:17359–17370.
96. M.Rinnerthaler, S.Buttner, P.Laun, G.Heeren, T.K.Felder, H.Klinger,. Yno1p/Aim14p, a NADPH-oxidase ortholog, controls extramitochondrial reactive oxygen species generation, apoptosis, and actin cable formation in yeast. Proc Natl Acad Sci U S A 2012;109:8658–8663.
97. J.J.Mei, S.D.Hursting, S.N.Perkins, J.M.Phang p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages. Cancer Lett 1998;129:191–197.
98. J.S.Won, Y.B.Im, L.Key, I.Singh, A.K.Singh The involvement of glucose metabolism in the regulation of inducible nitric oxide synthase gene expression in glial cells:possible role of glucose-6-phosphate dehydrogenase and CCAAT/enhancing binding protein. J Neurosci 2003;23:7470–7478.
99. J.A.Leopold, A.Cap, A.W.Scribner, R.C.Stanton, J.Loscalzo Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J 2001;15:1771–1773.
100. J.A.Leopold, Y.Y.Zhang, A.W.Scribner, R.C.Stanton, J.Loscalzo Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler Thromb Vasc Biol 2003;23:411–417.
101. J.A.Leopold, J.Walker, A.W.Scribner, B.Voetsch, Y.Y.Zhang, A.J.Loscalzo,. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J Biol Chem 2003;278:32100–32106.
102. L.Kayser, J.Thomsen Glucose-6-phosphate dehydrogenase activity in monolayer cultures of thyroid epithelial cells:TSH and inhibition of nitrogen oxide synthase affect the enzyme activity and the oxygen sensitivity of the histochemical assay. Acta Histochem 2005;107:31–41.
103. A.P.Rosa, C.E.Jacques, L.O.de Souza, F.Bitencourt, P.N.Mazzola, J.G.Coelho,. Neonatal hyperglycemia induces oxidative stress in the rat brain:the role of pentose phosphate pathway enzymes and NADPH oxidase. Mol Cell Biochem 2015;403:159–167.
104. S.Serpillon, B.C.Floyd, R.S.Gupte, S.George, M.Kozicky, V.Neito,. Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. Am J Physiol Heart Circ Physiol 2009;297:H153–H162.
105. R.S.Gupte, B.C.Floyd, M.Kozicky, S.George, Z.I.Ungvari, V.Neito,. Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver. Free Radic Biol Med 2009;47:219–228.
106. S.A.Gupte, R.J.Levine, R.S.Gupte, M.E.Young, V.Lionetti, V.Labinskyy,. Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. J Mol Cell Cardiol 2006;41:340–349.
107. S.A.Gupte, P.M.Kaminski, B.Floyd, R.Agarwal, N.Ali, M.Ahmad,. Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol 2005;288:H13–H21.
108. R.Matsui, S.Xu, K.A.Maitland, A.Hayes, J.A.Leopold, D.E.Handy,. Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II. Circulation 2005;112:257–263.
109. N.Y.Spencer, Z.Yan, R.L.Boudreau, Y.Zhang, M.Luo, Q.Li,. Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4. J Biol Chem 2011;286:8977–8987.
110. O.S.Gammoh, A.Al-Smadi, W.Al-Awaida, M.M.Badr, N.A.Qinna Increased salivary nitric oxide and G6PD activity in refugees with anxiety and stress. Stress Health 2015. [Epub ahead of print]. doi:10.1002/smi.2666.
111. J.W.Lee, A.H.Choi, M.Ham, J.W.Kim, S.S.Choe, J.Park,. G6PD up-regulation promotes pancreatic beta-cell dysfunction. Endocrinology 2011;152:793–803.
112. J.Park, S.S.Choe, A.H.Choi, K.H.Kim, M.J.Yoon, T.Suganami,. Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals. Diabetes 2006;55:2939–2949.
113. R.Matsui, S.Xu, K.A.Maitland, R.Mastroianni, J.A.Leopold, D.E.Handy,. The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Arterioscler Thromb Vasc Biol 2006;26:910–916.
114. M.L.Cheng, H.Y.Ho, C.M.Liang, Y.H.Chou, A.Stern, F.J.Lu, D.T.Chiu Cellular glucose-6-phosphate dehydrogenase (G6PD) status modulates the effects of nitric oxide (NO) on human foreskin fibroblasts. FEBS Lett 2000;475:257–262.
115. A.R.Cross, A.W.Segal The NADPH oxidase of professional phagocytes–prototype of the NOX electron transport chain systems. Biochim Biophys Acta 2004;1657:1–22.
116. H.M.Abu-Soud, A.Presta, B.Mayer, D.J.Stuehr Analysis of neuronal NO synthase under single-turnover conditions:conversion of N-omega-hydroxyarginine to nitric oxide and citrulline. Biochemistry 1997;36:10811–10816.
117. R.A.Clark, K.G.Leidal, D.W.Pearson, W.M.Nauseef NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonate-activatable superoxide-generating system. J Biol Chem 1987;262:4065–4074.
118. R.C.Stanton Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 2012;64:362–369.
119. H.Motohashi, M.Yamamoto Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004;10:549–557.
120. K.S.Chun, J.Kundu, J.K.Kundu, Y.J.Surh Targeting Nrf2-Keap1 signaling for chemoprevention of skin carcinogenesis with bioactive phytochemicals. Toxicol Lett 2014;229:73–84.
121. S.Kim, H.G.Lee, S.A.Park, J.K.Kundu, Y.S.Keum, Y.N.Cha,. Keap1 cysteine 288 as a potential target for diallyl trisulfide-induced Nrf2 activation. PLoS One 2014;9:e85984.
122. H.K.Na, Y.J.Surh Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1. Free Radic Biol Med 2014;67:353–365.
123. W.Kim, H.U.Kim, H.N.Lee, S.H.Kim, C.Kim, Y.N.Cha,. Taurine chloramine stimulates efferocytosis through upregulation of Nrf2-mediated heme oxygenase-1 expression in murine macrophages:possible involvement of carbon monoxide. Antioxid Redox Signal 2015;23:163–177.
124. J.M.Park, D.H.Kim, H.K.Na, Y.J.Surh Methylseleninic acid induces NAD(P)H:quinone oxidoreductase-1 expression through activation of NF-E2-related factor 2 in Chang liver cells. Oncotarget 2016. [Epub ahead of print]. doi:10.18632/oncotarget.10289.
125. S.A.Park, M.H.Lee, H.K.Na, Y.J.Surh 4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression. Oncotarget 2016. [Epub ahead of print]. doi:10.18632/oncotarget.10516.
126. H.R.Lin, C.C.Wu, Y.H.Wu, C.W.Hsu, M.L.Cheng, D.T.Chiu Proteome-wide dysregulation by glucose-6-phosphate dehydrogenase (G6PD) reveals a novel protective role for G6PD in aflatoxin B(1)-mediated cytotoxicity. J Proteome Res 2013;12:3434–3448.
127. B.M.Hybertson, B.Gao, S.K.Bose, J.M.McCord Oxidative stress in health and disease:the therapeutic potential of Nrf2 activation. Mol Aspects Med 2011;32:234–246.
128. E.H.Heiss, D.Schachner, K.Zimmermann, V.M.Dirsch Glucose availability is a decisive factor for Nrf2-mediated gene expression. Redox Biol 2013;1:359–365.
129. H.C.Yang, M.L.Cheng, Y.S.Hua, Y.H.Wu, H.R.Lin, H.Y.Liu,. Glucose 6-phosphate dehydrogenase knockdown enhances IL-8 expression in HepG2 cells via oxidative stress and NF-kappaB signaling pathway. J Inflamm (Lond) 2015;12:34.
130. Y.C.Chao, C.S.Huang, C.N.Lee, S.Y.Chang, C.C.King, C.L.Kao Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency. PLoS One 2008;3:e1557.
131. Y.H.Wu, C.P.Tseng, M.L.Cheng, H.Y.Ho, S.R.Shih, D.T.Chiu Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection. J Infect Dis 2008;197:812–816.
132. H.Y.Ho, M.L.Cheng, S.F.Weng, L.Chang, T.T.Yeh, S.R.Shih, D.T.Chiu Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol 2008;89:2080–2089.
133. Y.T.Hsieh, M.H.Lin, H.Y.Ho, L.C.Chen, C.C.Chen, J.C.Shu Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus. PLoS One 2013;8:e79566.
134. M.Ham, J.W.Lee, A.H.Choi, H.Jang, G.Choi, J.Park,. Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress. Proc Natl Acad Sci USA 2013;33:2425–2435.
135. Y.H.Wu, D.T.Chiu, H.R.Lin, H.Y.Tang, M.L.Cheng, H.Y.Ho Glucose-6-phosphate dehydrogenase enhances antiviral response through downregulation of NADPH sensor HSCARG and upregulation of NF-kappaB signaling. Viruses 2015;7:6689–6706.
136. X.Zheng, X.Dai, Y.Zhao, Q.Chen, F.Lu, D.Yao,. Restructuring of the dinucleotide-binding fold in an NADP(H) sensor protein. Proc Natl Acad Sci USA 2007;104:8809–8814.
137. X.Dai, Y.Li, G.Meng, S.Yao, Y.Zhao, Q.Yu,. HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination. J Mol Biol 2009;387:1277–1285.
138. M.Lian, X.Zheng HSCARG regulates NF-kappaB activation by promoting the ubiquitination of RelA or COMMD1. J Biol Chem 2009;284:17998–18006.
139. T.Li, J.Guan, S.Li, X.Zhang, X.Zheng HSCARG downregulates NF-kappaB signaling by interacting with USP7 and inhibiting NEMO ubiquitination. Cell Death Dis 2014;5:e1229.
140. Q.Gan, T.Li, B.Hu, M.Lian, X.Zheng HSCARG inhibits activation of NF-kappaB by interacting with IkappaB kinase-beta. J Cell Sci 2009;122:4081–4088.
141. R.Barcia-Vieitez, J.I.Ramos-Martinez The regulation of the oxidative phase of the pentose phosphate pathway:new answers to old problems. IUBMB Life 2014;66:775–779.
142. Y.Peng, R.Xu, X.Zheng HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1. PLoS Pathog 2014;10:e1004041.
143. Y.Zhao, J.Zhang, H.Li, Y.Li, J.Ren, M.Luo, X.Zheng An NADPH sensor protein (HSCARG) down-regulates nitric oxide synthesis by association with argininosuccinate synthetase and is essential for epithelial cell viability. J Biol Chem 2008;283:11004–11013.
144. W.Xiao, Y.Peng, Y.Liu, Z.Li, S.Li, X.Zheng HSCARG inhibits NADPH oxidase activity through regulation of the expression of p47phox. PLoS One 2013;8:e59301.
145. M.Philippe, Y.Larondelle, F.Lemaigre, B.Mariame, H.Delhez, P.Mason,. Promoter function of the human glucose-6-phosphate dehydrogenase gene depends on two GC boxes that are cell specifically controlled. Comp Biochem Physiol B Biochem Mol Biol 1994;226:377–384.
146. A.Franze, M.I.Ferrante, F.Fusco, A.Santoro, E.Sanzari, G.Martini, M.V.Ursini Molecular anatomy of the human glucose 6-phosphate dehydrogenase core promoter. FEBS Lett 1998;437:313–318.
147. G.P.Laliotis, I.Bizelis, A.Argyrokastritis, E.Rogdakis Cloning, characterization and computational analysis of the 5' regulatory region of ovine glucose 6-phosphate dehydrogenase gene. Comp Biochem Physiol B Biochem Mol Biol 2007;147:627–634.
148. S.Chettimada, S.R.Joshi, A.Alzoubi, S.A.Gebb, I.F.McMurtry, R.Gupte, S.A.Gupte Glucose-6-phosphate dehydrogenase plays a critical role in hypoxia-induced CD133+ progenitor cells self-renewal and stimulates their accumulation in the lungs of pulmonary hypertensive rats. Am J Physiol Lung Cell Mol Physiol 2014;307:L545–L556.
149. S.Chettimada, R.Gupte, D.Rawat, S.A.Gebb, I.F.McMurtry, S.A.Gupte Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells:implication in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2015;308:L287–L300.
150. M.A.Keller, A.V.Turchyn, M.Ralser Non-enzymatic glycolysis and pentose phosphate pathway-like reactions in a plausible Archean ocean. Mol Syst Biol 2014;10:725.
151. A.Kruger, N.M.Gruning, M.M.Wamelink, M.Kerick, A.Kirpy, D.Parkhomchuk,. The pentose phosphate pathway is a metabolic redox sensor and regulates transcription during the antioxidant response. Antioxid Redox Signal 2011;15:311–324.
152. K.R.Sekhar, M.L.Freeman Nrf2 promotes survival following exposure to ionizing radiation. Free Radic Biol Med 2015;88:268–274.
153. L.E.Tebay, H.Robertson, S.T.Durant, S.R.Vitale, T.M.Penning, A.T.Dinkova-Kostova, J.D.Hayes Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med 2015;88:108–146.
154. P.D.Ray, B.W.Huang, Y.Tsuji Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012;24:981–990.
155. C.Godon, G.Lagniel, J.Lee, J.M.Buhler, S.Kieffer, M.Perrot,. The H2O2 stimulon in Saccharomyces cerevisiae. J Biol Chem 1998;273:22480–22489.
156. H.Y.Tang, H.Y.Ho, P.R.Wu, S.H.Chen, F.A.Kuypers, M.L.Cheng, D.T.Chiu Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal 2015;22:744–759.
157. A.Kuehne, H.Emmert, J.Soehle, M.Winnefeld, F.Fischer, H.Wenck,. Acute activation of oxidative pentose phosphate pathway as first-line response to oxidative stress in human skin cells. Mol Cell 2015;59:359–371.
158. H.Y.Ho, M.L.Cheng, M.S.Shiao, D.T.Chiu Characterization of global metabolic responses of glucose-6-phosphate dehydrogenase-deficient hepatoma cells to diamide-induced oxidative stress. Free Radic Biol Med 2013;54:71–84.
159. D.Anastasiou, G.Poulogiannis, J.M.Asara, M.B.Boxer, J.K.Jiang, M.Shen,. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011;334:1278–1283.
160. M.Ralser, M.M.Wamelink, S.Latkolik, E.E.Jansen, H.Lehrach, C.Jakobs Metabolic reconfiguration precedes transcriptional regulation in the antioxidant response. Nat Biotechnol 2009;27:604–605.
161. N.Ozer, Y.Aksoy, I.H.Ogus Kinetic properties of human placental glucose-6-phosphate dehydrogenase. Int J Biochem Cell Biol 2001;33:221–226.
162. S.W.Cho, J.G.Joshi Characterization of glucose-6-phosphate dehydrogenase isozymes from human and pig brain. Neuroscience 1990;38:819–828.
163. D.G.Hardie, F.A.Ross, S.A.Hawley AMPK:a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012;13:251–262.
164. B.Xiao, R.Heath, P.Saiu, F.C.Leiper, P.Leone, C.Jing,. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 2007;449:496–500.
165. J.M.Lizcano, O.Goransson, R.Toth, M.Deak, N.A.Morrice, J.Boudeau,. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 2004;23:833–843.
166. G.Herrero-Martin, M.Hoyer-Hansen, C.Garcia-Garcia, C.Fumarola, T.Farkas, A.Lopez-Rivas, M.Jaattela TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J 2009;28:677–685.
167. D.G.Hardie Sensing of energy and nutrients by AMP-activated protein kinase. Am J Clin Nutr 2011;93:891S–896S.
168. B.Xiao, M.J.Sanders, E.Underwood, R.Heath, F.V.Mayer, D.Carmena,. Structure of mammalian AMPK and its regulation by ADP. Nature 2011;472:230–233.
169. R.Rafaeloff-Phail, L.Ding, L.Conner, W.K.Yeh, D.McClure, H.Guo,. Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH. Proc Natl Acad Sci USA 2004;279:52934–52939.
170. I.Tabidi, D.Saggerson Inactivation of the AMP-activated protein kinase by glucose in cardiac myocytes:a role for the pentose phosphate pathway. Biosci Rep 2012;32:229–239.
171. C.H.Waddington Preliminary notes on the development of the wings in normal and mutant strains of drosophila. Proc Natl Acad Sci USA 1939;25:299–307.
172. X.Paez-Colasante, C.Figueroa-Romero, S.A.Sakowski, S.A.Goutman, E.L.Feldman Amyotrophic lateral sclerosis:mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol 2015;11:266–279.
173. J.M.Bautista. Recent trends for novel options in experimental biological therapy of β-thalassemia. Blood 2014;124:7–8.
174. K.E.Glajch, G.Sadri-Vakili Epigenetic mechanisms involved in Huntington's disease pathogenesis. J Huntingtons Dis 2015;4:1–15.
175. A.Finotti, R.Gambari Recent trends for novel options in experimental biological therapy of beta-thalassemia. Expert Opin Biol Ther 2014;14:1443–1454.
176. A.D.Dekker, P.P.De Deyn, M.G.Rots Epigenetics:the neglected key to minimize learning and memory deficits in Down syndrome. Neurosci Biobehav Rev 2014;45:72–84.
177. A.Aartsma-Rus, I.Fokkema, J.Verschuuren, I.Ginjaar, J.van Deutekom, G.J.van Ommen, J.T.den Dunnen Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat 2009;30:293–299.
178. K.Makarona, V.S.Caputo, J.R.Costa, B.Liu, D.O'Connor, D.Iskander,. Transcriptional and epigenetic basis for restoration of G6PD enzymatic activity in human G6PD-deficient cells. Blood 2014;124:134–141.
179. D.M.Coda, M.F.Lingua, D.Morena, V.Foglizzo, F.Bersani, U.Ala,. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma. Cell Cycle 2015;14:1389–1402.
180. H.K.Kim, Y.S.Lee, U.Sivaprasad, A.Malhotra, A.Dutta Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006;174:677–687.
181. J.F.Chen, Y.Tao, J.Li, Z.Deng, Z.Yan, X.Xiao, D.Z.Wang microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 2010;190:867–879.
182. W.H.Townley-Tilson, T.E.Callis, D.Wang MicroRNAs 1, 133, and 206:critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol 2010;42:1252–1255.
183. D.Cacchiarelli, J.Martone, E.Girardi, M.Cesana, T.Incitti, M.Morlando,. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab 2010;12:341–351.
184. L.Wang, Y.Yuan, J.Li, H.Ren, Q.Cai, X.Chen,. MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network. Cell Stress Chaperones 2015;20:411–420.
185. A.O.Babalola, J.G.Beetlestone, L.Luzzatto Genetic variants of human erythrocyte glucose-6-phosphate dehydrogenase. Kinetic and thermodynamic parameters of variants A, B, and A- in relation to quaternary structure. J Biol Chem 1976;251:2993–3002.
186. P.Cohen, M.A.Rosemeyer Human glucose-6-phosphate dehydrogenase:purification of the erythrocyte enzyme and the influence of ions on its activity. Eur J Biochem 1969;8:1–7.
187. S.C.Kim, R.Sprung, Y.Chen, Y.Xu, H.Ball, J.Pei,. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006;23:607–618.
188. C.Choudhary, C.Kumar, F.Gnad, M.L.Nielsen, M.Rehman, T.C.Walther,. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009;325:834–840.
189. S.Zhao, W.Xu, W.Jiang, W.Yu, Y.Lin, T.Zhang,. Regulation of cellular metabolism by protein lysine acetylation. Science 2010;327:1000–1004.
190. A.Lundby, K.Lage, B.T.Weinert, D.B.Bekker-Jensen, A.Secher, T.Skovgaard,. Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Rep 2012;2:419–431.
191. Y.P.Wang, L.S.Zhou, Y.Z.Zhao, S.W.Wang, L.L.Chen, L.X.Liu,. Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress. EMBO J 2014;33:1304–1320.
192. R.Lin, R.Tao, X.Gao, T.Li, X.Zhou, K.L.Guan, Y.Xiong, Q.Y.Lei Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell 2013;51:506–518.
193. D.Zhao, S.W.Zou, Y.Liu, X.Zhou, Y.Mo, P.Wang,. Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Cancer Cell 2013;23:464–476.
194. T.Hitosugi, L.Zhou, J.Fan, S.Elf, L.Zhang, J.Xie,. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation. Nat Commun 2013;4:1790.
195. J.Fan, T.Hitosugi, T.W.Chung, J.Xie, Q.Ge, T.L.Gu,. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells. Mol Cell Biol 2011;31:4938–4950.
196. V.Dehennaut, M.C.Slomianny, A.Page, A.S.Vercoutter-Edouart, C.Jessus, J.C.Michalski,. Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte. Mol Cell Proteomics 2008;7:2229–2245.
197. W.Yi, P.M.Clark, D.E.Mason, M.C.Keenan, C.Hill, W.A.GoddardIII,. Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science 2012;337:975–980.
198. G.W.Hart, M.P.Housley, C.Slawson Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007;446:1017–1022.
199. J.E.Rexach, P.M.Clark, L.C.Hsieh-Wilson Chemical approaches to understanding O-GlcNAc glycosylation in the brain. Nat Chem Biol 2008;4:97–106.
200. Z.Li, W.Yi Regulation of cancer metabolism by O-GlcNAcylation. Glycoconj J 2014;31:185–191.
201. X.Rao, X.Duan, W.Mao, X.Li, Z.Li, Q.Li,. O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth. Nat Commun 2015;6:8468.
202. S.Matsubara, T.Kato, K.Oshikawa, T.Yamada, T.Takayama, T.Koike,. Glucose-6-phosphate dehydrogenase in rat lung alveolar epithelial cells. An ultrastructural enzyme-cytochemical study. Eur J Histochem 2002;46:243–248.
203. S.Matsubara Simultaneous demonstration of acid phosphatase and glucose-6-phosphate dehydrogenase in mouse hepatocytes. A novel electron-microscopic dual staining enzyme-cytochemistry. Eur J Histochem 2002;46:237–242.
204. S.Matsubara, D.Matsubara, T.Yamada, T.Koike, I.Sato Glucose-6-phosphate dehydrogenase in rat hepatic stellate cells:an ultrastructural enzyme-cytochemical study. Hepatol Res 2002;24:300.
205. P.Ninfali, M.Malatesta, E.Biagiotti, G.Aluigi, G.Gazzanelli Glucose-6-phosphate dehydrogenase in small intestine of rabbit:biochemical properties and subcellular localization. Acta Histochem 2001;103:287–303.
206. T.Ishibashi, T.Takizawa, H.Iwasaki, T.Saito, S.Matsubara, E.Nakazawa, K.Kanazawa Glucose-6-phosphate dehydrogenase cytochemistry using a copper ferrocyanide method and its application to rapidly frozen cells. Histochem Cell Biol 1999;112:221–232.
207. R.F.Kletzien, P.K.Harris, L.A.Foellmi Glucose-6-phosphate dehydrogenase:a “housekeeping” enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J 1994;8:174–181.
208. Z.Zhang, Z.Yang, B.Zhu, J.Hu, C.W.Liew, Y.Zhang,. Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose. PLoS One 2012;7:e49128.
209. N.Y.Spencer, Z.Yan, L.Cong, Y.Zhang, J.F.Engelhardt, R.C.Stanton Definitive localization of intracellular proteins:Novel approach using CRISPR-Cas9 genome editing, with glucose 6-phosphate dehydrogenase as a model. Anal Biochem 2016;494:55–67.
210. E.Lizotte, A.Tremblay, B.G.Allen, C.Fiset Isolation and characterization of subcellular protein fractions from mouse heart. Anal Biochem 2005;345:47–54.
211. L.Guo, Z.Zhang, K.Green, R.C.Stanton Suppression of interleukin-1 beta-induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase. Biochemistry 2002;41:14726–14733.
212. W.N.Tian, L.D.Braunstein, J.Pang, K.M.Stuhlmeier, Q.C.Xi, X.Tian, R.C.Stanton Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem 1998;273:10609–10617.
213. H.Y.Ho, M.L.Cheng, F.J.Lu, Y.H.Chou, A.Stern, C.M.Liang, D.T.Chiu Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts. Free Radic Biol Med 2000;29:156–169.
214. D.Li, Y.Zhu, Q.Tang, H.Lu, H.Li, Y.Yang,. A new G6PD knockdown tumor-cell line with reduced proliferation and increased susceptibility to oxidative stress. Cancer Biother Radiopharm 2009;24:81–90.
215. C.J.Lin, H.Y.Ho, M.L.Cheng, T.H.You, J.S.Yu, D.T.Chiu Impaired dephosphorylation renders G6PD-knockdown HepG2 cells more susceptible to H(2)O(2)-induced apoptosis. Free Radic Biol Med 2010;49:361–373.
216. E.Tsouko, A.S.Khan, M.A.White, J.J.Han, Y.Shi, F.A.Merchant,. Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis 2014;3:e103.
217. R.Lin, S.Elf, C.Shan, H.B.Kang, Q.Ji, L.Zhou, T.Hitosugi,. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nat Cell Biol 2015;17:1484–1496.
218. S.K.Jonas, C.Benedetto, A.Flatman, R.H.Hammond, L.Micheletti, C.Riley,. Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia. Br J Cancer 1992;66:185–191.
219. E.Sulis G.-6-P.D. deficiency and cancer. Lancet 1972;1:1185.
220. K.C.Patra, N.Hay The pentose phosphate pathway and cancer. Trends Biochem Sci 2014;39:347–354.
221. C.Farquharson, J.Milne, N.Loveridge Mitogenic action of insulin-like growth factor-I on human osteosarcoma MG-63 cells and rat osteoblasts maintained in situ:the role of glucose-6-phosphate dehydrogenase. Bone Miner 1993;22:105–115.
222. C.R.Dworkin, S.D.Gorman, L.L.Pashko, V.J.Cristofalo, A.G.Schwartz Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo- and deoxyribonucleosides. Life Sci 1986;38:1451–1457.
223. F.Dickens Oxidation of phosphohexonate and pentose phosphoric acids by yeast enzymes:Oxidation of phosphohexonate. II. Oxidation of pentose phosphoric acids. Biochem J 1938;32:1626–1644.
224. D.Thomas, H.Cherest, Y.Surdin-Kerjan Identification of the structural gene for glucose-6-phosphate dehydrogenase in yeast. Inactivation leads to a nutritional requirement for organic sulfur. EMBO J 1991;10:547–553.
225. I.Nogae, M.Johnston Isolation and characterization of the ZWF1 gene of Saccharomyces cerevisiae, encoding glucose-6-phosphate dehydrogenase. Gene 1990;96:161–169.
226. D.Grabowska, A.Chelstowska The ALD6 gene product is indispensable for providing NADPH in yeast cells lacking glucose-6-phosphate dehydrogenase activity. J Biol Chem 2003;278:13984–13988.
227. K.H.Slekar, D.J.Kosman, V.C.Culotta The yeast copper/zinc superoxide dismutase and the pentose phosphate pathway play overlapping roles in oxidative stress protection. J Biol Chem 1996;271:28831–28836.
228. S.Filosa, A.Fico, F.Paglialunga, M.Balestrieri, A.Crooke, P.Verde,. Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. Biochem J 2003;370:935–943.
229. A.Fico, F.Paglialunga, L.Cigliano, P.Abrescia, P.Verde, G.Martini,. Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death Differ 2004;11:823–831.
230. F.Paglialunga, A.Fico, I.Iaccarino, R.Notaro, L.Luzzatto, G.Martini, S.Filosa G6PD is indispensable for erythropoiesis after the embryonic-adult hemoglobin switch. Blood 2004;104:3148–3152.
231. C.J.Nicol, J.Zielenski, L.C.Tsui, P.G.Wells An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J 2000;14:111–127.
232. M.Perez-Crespo, M.A.Ramirez, R.Fernandez-Gonzalez, D.Rizos, P.Lonergan, B.Pintado, A.Gutierrez-Adan Differential sensitivity of male and female mouse embryos to oxidative induced heat-stress is mediated by glucose-6-phosphate dehydrogenase gene expression. Mol Reprod Dev 2005;72:502–510.
233. X.Patrinostro, M.L.Carter, A.C.Kramer, T.C.Lund A model of glucose-6-phosphate dehydrogenase deficiency in the zebrafish. Exp Hematol 2013;41:697–710e2.
234. F.Urner, D.Sakkas Involvement of the pentose phosphate pathway and redox regulation in fertilization in the mouse. Mol Reprod Dev 2005;70:494–503.
235. C.Cosentino, D.Grieco, V.Costanzo. Dehydroepiandrosterone promotes pulmonary artery relaxation by NADPH oxidation-elicited subunit dimerization of protein kinase G 1α. EMBO J 2011;30:546–555.
236. K.M.Aird, A.J.Worth, N.W.Snyder, J.V.Lee, S.Sivanand, Q.Liu,. ATM couples replication stress and metabolic reprogramming during cellular senescence. Cell Rep 2015;11:893–901.
237. D.Patel, S.Kandhi, M.Kelly, B.H.Neo, M.S.Wolin Dehydroepiandrosterone promotes pulmonary artery relaxation by NADPH oxidation-elicited subunit dimerization of protein kinase G 1alpha. Am J Physiol Lung Cell Mol Physiol 2014;306:L383–L391.
238. M.S.Tsao, H.S.Earp, J.W.Grisham The effects of epidermal growth factor and the state of confluence on enzymatic activities of cultured rat liver epithelial cells. J Cell Physiol 1986;126:167–173.
239. X.Preville, F.Salvemini, S.Giraud, S.Chaufour, C.Paul, G.Stepien,. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp Cell Res 1999;247:61–78.
240. L.M.Salati, B.Adkins-Finke, S.D.Clarke Free fatty acid inhibition of the insulin induction of glucose-6-phosphate dehydrogenase in rat hepatocyte monolayers. Lipids 1988;23:36–41.
241. B.Liu, M.Fang, Z.He, D.Cui, S.Jia, X.Lin,. Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation. Cell Death Dis 2015;6:e1980.
242. W.N.Tian, J.N.Pignatare, R.C.Stanton Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells. J Biol Chem 1994;269:14798–14805.
243. A.Thakur, K.W.Rahman, J.Wu, A.Bollig, H.Biliran, X.Lin,. Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer. Mol Cancer Res 2007;5:171–181.
244. S.Pan, C.J.World, C.J.Kovacs, B.C.Berk. Comparative effectiveness of vitamin D3 and dietary vitamin E on peroxidation of lipids and enzymes of the hepatic antioxidant system in Sprague-Dawley rats. Arterioscler Thromb Vasc Biol 2009;29:895–901.
245. M.Li, M.Sun, L.Cao, J.H.Gu, J.Ge, J.Chen,. A TIGAR-regulated metabolic pathway is critical for protection of brain ischemia. J Neurosci 2014;34:7458–7471.
246. S.Sardar, A.Chakraborty, M.Chatterjee Comparative effectiveness of vitamin D3 and dietary vitamin E on peroxidation of lipids and enzymes of the hepatic antioxidant system in Sprague–Dawley rats. Int J Vitam Nutr Res 1996;66:39–45.
247. J.A.Leopold, A.Dam, B.A.Maron, A.W.Scribner, R.Liao, D.E.Handy,. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 2007;13:189–197.
248. A.B.Kohan, I.Talukdar, C.M.Walsh, L.M.Salati A role for AMPK in the inhibition of glucose-6-phosphate dehydrogenase by polyunsaturated fatty acids. Biochem Biophys Res Commun 2009;388:117–121.
249. I.Talukdar, W.Szeszel-Fedorowicz, L.M.Salati Arachidonic acid inhibits the insulin induction of glucose-6-phosphate dehydrogenase via p38 MAP kinase. J Biol Chem 2005;280:40660–40667.
250. Z.Zhang, K.Apse, J.Pang, R.C.Stanton High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem 2000;275:40042–40047.
251. P.Jiang, W.Du, X.Wang, A.Mancuso, X.Gao, M.Wu, X.Yang p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol 2011;13:310–316.
252. D.T.Chiu Helmut sies:a continuous presence in my scientific development. Arch Biochem Biophys 2016;595:181–184.